ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,284.12
      -0.07%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mei Pharma, Inc. (MM) (MSHL)

      7. Mei Pharma, Inc. (MM) (MSHL) News

      MSHL

      Marshall Edwards (MSHL)

      Mei Pharma, Inc. (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MSHL
      DateTimeSourceHeadlineSymbolCompany
      2:15PMiHub NewswireFeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio
      07/09/20122:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
      07/05/20124:03PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
      07/02/20123:18PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
      06/28/20129:00AMPR Newswire (US)Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")NASDAQ:MSHLMei Pharma, Inc. (MM)
      06/06/20126:04AMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
      06/05/20125:28PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
      06/04/20129:00AMPR Newswire (US)Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143NASDAQ:MSHLMei Pharma, Inc. (MM)
      05/29/20129:00AMPR Newswire (US)Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344NASDAQ:MSHLMei Pharma, Inc. (MM)
      05/25/20121:32PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:MSHLMei Pharma, Inc. (MM)
      05/15/20123:27PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
      05/15/20121:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
      05/15/20121:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
      05/15/20121:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
      05/15/201210:05AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MSHLMei Pharma, Inc. (MM)
      05/14/20129:00AMPR Newswire (US)Marshall Edwards Completes Rights Offering To StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
      05/08/20129:00AMPR Newswire (US)Marshall Edwards Receives $4 Million Subscription From Novogen In Rights OfferingNASDAQ:MSHLMei Pharma, Inc. (MM)
      04/25/20129:00AMPR Newswire (US)Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating CancerNASDAQ:MSHLMei Pharma, Inc. (MM)
      04/13/20123:59PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
      04/11/20122:41PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
      04/10/20129:00AMPR Newswire (US)Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...NASDAQ:MSHLMei Pharma, Inc. (MM)
      04/03/20129:00AMPR Newswire (US)Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual MeetingNASDAQ:MSHLMei Pharma, Inc. (MM)
      03/30/201212:34PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
      03/30/201212:32PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
      03/28/20129:00AMPR Newswire (US)Marshall Edwards CEO to Present at Needham Healthcare ConferenceNASDAQ:MSHLMei Pharma, Inc. (MM)
      03/27/20129:00AMPR Newswire (US)Marshall Edwards Receives Notice of Effectiveness for Rights Offering to StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
      03/27/20126:02AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:MSHLMei Pharma, Inc. (MM)
      03/26/20124:40PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
      03/20/20128:55AMEdgar (US Regulatory)Securities Registration Statement (S-1/A)NASDAQ:MSHLMei Pharma, Inc. (MM)
      03/19/20129:00AMPR Newswire (US)Marshall Edwards Announces Terms for Rights Offering to StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
       Showing the most relevant articles for your search:NASDAQ:MSHL